United States Healthcare Providers & Services

Privia Health Group Inc (PRVA)

Track

Over the last 90 days, Privia Health Group Inc. has seen significant insider selling, with a net value of -$3.77 million. Executives were the primary sellers. Notable transactions include large planned and proposed sales by CEO Parth Mehrotra and EVP & CFO David Mountcastle. The stock has experienced a 4.6% price increase over the same period.
Stock chart
Ticker: PRVA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Mehrotra Parth
Chief Executive Officer
2 sales — total 454,248 USD
Planned sale 12 May 2026
Value US$4,369,331.75 | Price 43.84 | Shares 96,564
Proposed sale 12 May 2026
Value US$3,811,612.25 | Price 491.20 | Shares 87,128
Planned sale 11 May 2026
Value US$3,168,223.04 | Price 419.90 | Shares 31,461
Proposed sale 11 May 2026
Value US$1,001,871.88 | Price 119.17 | Shares 51,577
Proposed sale 11 May 2026
Value US$317,262.72 | Price 22.60 | Shares 14,036
Sale 11 May 2026
Value US$100,000.00 | Price 22.60 | Shares 1,000
Proposed sale 11 May 2026
Value US$76,512.85 | Price 22.60 | Shares 3,385
Planned sale 4 May 2026
Value US$30,150.00 | Price 25.00 | Shares 1,206
Proposed sale 4 May 2026
Value US$30,150.00 | Price 25.00 | Shares 1,206
Planned sale 4 May 2026
Value US$25,384.32 | Price 24.96 | Shares 1,017
Planned sale 1 May 2026
Value US$179,690.37 | Price 25.03 | Shares 7,179
Proposed sale 1 May 2026
Value US$179,680.69 | Price 25.03 | Shares 7,179
Planned sale 1 May 2026
Value US$427,229.04 | Price 24.99 | Shares 17,096
Proposed sale 1 May 2026
Value US$40,472,772.55 | Price 24.85 | Shares 1,628,683
Sale 2 Apr 2026
Value US$116,051.10 | Price 20.85 | Shares 5,566
Proposed sale 2 Apr 2026
Value US$116,055.55 | Price 20.85 | Shares 5,566
Sale 16 Mar 2026
Value US$586,113.99 | Price 22.11 | Shares 26,509
Proposed sale 16 Mar 2026
Value US$586,108.69 | Price 22.11 | Shares 26,509
Sale 16 Mar 2026
Value US$141,305.01 | Price 22.11 | Shares 6,391
Proposed sale 16 Mar 2026
Value US$141,303.73 | Price 22.11 | Shares 6,391
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-12 PlS Planned sale
3.6
Mehrotra Parth

Chief Executive Officer

Executive Director
96,564 +26.3%
43.84
US$4,369,332 		96,564 +26.3% 43.84 US$4,369,332
2026-05-12 2026-05-12 PrS Proposed sale
3.6
Mehrotra Parth

Officer; Director

Executive Director
87,128
491.20
US$3,811,612 		87,128 491.20 US$3,811,612
2026-05-13 2026-05-11 PlS Planned sale
3.6
Mehrotra Parth

Chief Executive Officer

Executive Director
31,461 +47.2%
419.90
US$3,168,223 		31,461 +47.2% 419.90 US$3,168,223
2026-05-13 2026-05-11 S Sale
3.2
Mountcastle David

EVP & Chief Financial Officer

Officer
1,000 -1.6%
22.60
US$100,000 		1,000 -1.6% 22.60 US$100,000
2026-05-11 2026-05-11 PrS Proposed sale
3.6
Mehrotra Parth

Officer; Director

Executive Director
91,403
22.55
US$2,060,697 		91,403 22.55 US$2,060,697
2026-05-11 2026-05-11 PrS Proposed sale
3.2
Mountcastle David

Officer

Officer
3,385
22.60
US$76,513 		3,385 22.60 US$76,513
2026-05-11 2026-05-11 PrS Proposed sale
3.6
Mehrotra Parth

Officer; Director

Executive Director
14,036
22.60
US$317,263 		14,036 22.60 US$317,263
2026-05-05 2026-05-04 PlS Planned sale
3.2
Mountcastle David

EVP & Chief Financial Officer

Officer
1,206 -0.6%
25.00
US$30,150 		1,206 -0.6% 25.00 US$30,150
2026-05-05 2026-05-04 PlS Planned sale
3.7
Morris Matthew Shawn
Non-Executive Director
1,017 -1.5%
24.96
US$25,384 		1,017 -1.5% 24.96 US$25,384
2026-05-04 2026-05-04 PrS Proposed sale
3.2
Mountcastle David

Officer

Officer
1,206
25.00
US$30,150 		1,206 25.00 US$30,150
2026-05-05 2026-05-01 PlS Planned sale
3.2
Mountcastle David

EVP & Chief Financial Officer

Officer
7,179 -3.2%
25.03
US$179,690 		7,179 -3.2% 25.03 US$179,690
2026-05-05 2026-05-01 PlS Planned sale
3.7
Morris Matthew Shawn
Non-Executive Director
17,096 -20.0%
24.99
US$427,229 		17,096 -20.0% 24.99 US$427,229
2026-05-01 2026-05-01 PrS Proposed sale
3.2
Mountcastle David

Officer

Officer
7,179
25.03
US$179,681 		7,179 25.03 US$179,681
2026-05-01 2026-05-01 PrS Proposed sale
3.7
Matthew Shawn Morris

Director

Non-Executive Director
1,628,683
24.85
US$40,472,773 		1,628,683 24.85 US$40,472,773
2026-04-06 2026-04-02 S Sale
3.2
Mountcastle David

EVP & Chief Financial Officer

Officer
5,566 -2.5%
20.85
US$116,051 		5,566 -2.5% 20.85 US$116,051
2026-04-02 2026-04-02 PrS Proposed sale
3.2
Mountcastle David

Officer

Officer
5,566
20.85
US$116,056 		5,566 20.85 US$116,056
2026-03-18 2026-03-16 S Sale
3.6
Mehrotra Parth

Chief Executive Officer

Executive Director
26,509 -4.6%
22.11
US$586,114 		26,509 -4.6% 22.11 US$586,114
2026-03-18 2026-03-16 S Sale
3.2
Mountcastle David

EVP & Chief Financial Officer

Officer
6,391 -2.8%
22.11
US$141,305 		6,391 -2.8% 22.11 US$141,305
2026-03-16 2026-03-16 PrS Proposed sale
3.6
Mehrotra Parth

Officer; Director

Executive Director
26,509
22.11
US$586,109 		26,509 22.11 US$586,109
2026-03-16 2026-03-16 PrS Proposed sale
3.2
Mountcastle David

Officer

Officer
6,391
22.11
US$141,304 		6,391 22.11 US$141,304
Explore more

More insider trading research around Privia Health Group Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America